Clinical Scorecard: The Role of TyG-WHtR in Forecasting New Cases of Type 2 Diabetes Mellitus Among NAFLD Patients: Findings from a 12-Year Prospective Cohort Analysis
At a Glance
Category
Detail
Condition
Key Mechanisms
Insulin resistance and metabolic dysfunction in T2DM and NAFLD.
Target Population
Care Setting
Key Highlights
AUC
Guideline-Based Recommendations
Diagnosis
Management
I
n
c
l
u
d
e
s
p
e
c
i
f
i
c
l
i
f
e
s
t
y
l
e
i
n
t
e
r
v
e
n
t
i
o
n
s
o
r
p
h
a
r
m
a
c
o
l
o
g
i
c
a
l
o
p
t
i
o
n
s
.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Expand on treatment options for managing T2DM in NAFLD patients.
